SpeeDx in Europe

@plexpcr

SpeeDx an innovative MDx company. Delivering solutions for infectious disease ID and antibiotic resistance. RTs are not endorsements Global

Vrijeme pridruživanja: veljača 2017.

Tweetovi

Blokirali ste korisnika/cu @plexpcr

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @plexpcr

  1. proslijedio/la je Tweet
    3. velj

    Mycoplasma genitalium and antimicrobial resistance in Europe: a comprehensive review [abstract]

    Poništi
  2. 3. velj

    Attending in Dubai visit our regional partner Zahrawi medical to learn more about SpeeDx

    Poništi
  3. proslijedio/la je Tweet

    Well done team! Great to see our research in news coverage. Good for raising awareness of and to everyone. Thanks to - Research with benefits to patients

    Poništi
  4. 28. sij
    Poništi
  5. 24. sij

    Prevalence of rectal Mycoplasma genitalium in MSM in clinic. MG testing demonstrated significant association with use.

    Poništi
  6. proslijedio/la je Tweet
    21. sij

    Resistance guided therapy should be the gold standard for preserving antiobiotics.

    Poništi
  7. 16. sij

    evaluation of MG FleXible cartridge - Mycoplasma genitalium and in a simple format making MG testing more accessible

    Poništi
  8. 16. sij

    Evaluation of performance of new MG FleXible assay - first cartridge based Mycoplasma genitalium test which includes for this important Advances in to improve

    Poništi
  9. 15. sij

    Interesting follow up work on NATSAL data from on Mycoplasma genitalium and in general population. Complex affecting there's interesting etiology to discover

    Poništi
  10. proslijedio/la je Tweet
    13. sij

    BREAKING NEWS: SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care, focusing on women’s health and infectious diseases.

    Poništi
  11. 14. sij
    Poništi
  12. proslijedio/la je Tweet
    11. sij
    Poništi
  13. proslijedio/la je Tweet
    9. sij

    Michelle Cole from describing the GRASP programme and demonstrating increase in resistant isolates from sentinel testing over the past 18 years.

    Poništi
  14. proslijedio/la je Tweet
    9. sij

    Even though GC remains Ceftiaxone susceptible there is definite evidence of MIC creep in data

    , , i još njih 7
    Prikaži ovu nit
    Poništi
  15. proslijedio/la je Tweet
    9. sij

    Mycoplasma Genitalium AMR ongoing challenges ▶️ We need culture ▶️ MIC based guidance is not enough, important to think about clinical effect & drug distribution when making treatment choices Jørgen Jensen

    Poništi
  16. proslijedio/la je Tweet
    9. sij

    STIs are not just an inconvenience just because they are not life threatening Keep pushing STIs & up ⬆️⬆️ the global policy & funding agenda Teodora Wi 👏👏

    Poništi
  17. proslijedio/la je Tweet

    Fascinating had a gene for resistance before penicillin invented - Magnus Unemo, the godfather of Gonococcal resistance research

    , , i još njih 3
    Poništi
  18. proslijedio/la je Tweet
    9. sij

    Tweeting today for Do follow & AMR Twitter dreamteam! Theodora Wi opening today with fantastic overview How to address the challenge AMR in gonorrhoea

    Prikaži ovu nit
    Poništi
  19. proslijedio/la je Tweet
    9. sij

    An interesting and novel therapeutic target for M genitalium coming out of Parc Taulí and Vall d'Hebron hospitals

    Poništi
  20. 23. pro 2019.

    Wishing you all a safe and wonderful holiday with your and

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·